Healthcare and Life Science
Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism
Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other approaches ...
Clinical considerations & payer perspectives
Late October saw the annual gathering of oncologists and industry in Madrid for ESMO 2023, bringing with it a wave of new clinical results across cancers and a fresh round of questions concerning pricing, access and reimbursement. What are the key clinical takeaways raised by physician...
Event filming and webcasting at Slido
WaveFX writes...We love Slido and were thrilled to manage their latest webcast streaming directly into their platform, (which was a first). ...
Meet Cambridge brings Christmas cheer by supporting Toy Collection Initiative
The official conference and events bureau for Cambridge is marking the end of its 25th anniversary year by supporting a local Toy Drive to donate toys to children and young people who may otherwise not receive a gift this Christmas. Meet Cambridge, which invited representatives from it...
Guardtech appoint new Nordics & Baltics specialist to upscale cleanroom construction service in region
UK cleanroom design & build experts recruit Territory Manager Lars Strandljung to offer dedicated provision in Scandinavia and beyond ...
Dina van Well joins Salus Wellness this month
Salus Wellness says...we are very pleased to announce that Dina van Well has joined Salus Wellness this month. ...
Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board
Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, announces it has appointed Dr Nicola Thompson as Chair of its Board of Directors. Following its $10 million Series A financing earlier in the year1, the...
Evonetix announces agreement for revolutionary Gene Synthesis Platform with Analog Devices
Cambridge, UK, 06 December 2023 – EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semico...
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space. This has been driven by several factors, including the lack of long-term data, the imbalance of upside and downside risk between manufacturers and payers, and d...
Making AI work for you: 6 tips to future-proof your career
Career Ambitions writes...How do you feel about the rapid development in AI? Fascinated? Terrified? Maybe a little bit of both? Whilst the possibilities it offers are undoubtedly exciting, the alarming predictions in the media about how AI could kill certain jobs, has left many of us f...